NCT05957224

Brief Summary

Following a meal, in nondiabetic individuals, blood glucose rises to peak at 1hr and returns to baseline in 2 - 3 hours. In T2DM, this peak is higher and prolonged. Meal plans for persons with T2DM should comprise evenly spaced, complex carbohydrate portions in order to avoid post-prandial glucose spikes. Researchers have developed an expanded line of Caribbean-flavoured, low-calorie meal-replacement shakes which have been formulated to match the macronutrient and caloric content of a commercially available brand. In this trial investigators aim to (1) examine the change in glucose levels post intake of Caribbean vs the commercially available brand and (2) to conduct a comparative sensory analysis of the two shakes.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 24, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

July 24, 2023

Status Verified

July 1, 2023

Enrollment Period

6 months

First QC Date

July 5, 2023

Last Update Submit

July 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in plasma glucose concentration post oral intake of shake

    30 minutes, 60 minutes and 120 minutes post oral intake of shake

Secondary Outcomes (1)

  • Sensory analysis of taste, texture, smell and appearance of shakes

    within 1hour post oral intake of shake

Study Arms (2)

Shake 1 then Shake 2

EXPERIMENTAL

Participants will consume 1 bottle of shake 1 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 2.

Other: Shake 1 then Shake 2

Shake 2 then Shake 1

EXPERIMENTAL

Participants will consume 1 bottle of Shake 2 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 1.

Other: Shake 2 then Shake 1

Interventions

Oral administration of Caribbean low-calorie meal-replacement shake then commercial low-calorie meal-replacement shake

Shake 1 then Shake 2

Oral administration of commercial low-calorie meal-replacement shake then Caribbean low-calorie meal-replacement shake

Shake 2 then Shake 1

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of T2DM for any length of time,
  • last HbA1C (within the last 6 months) of \< / = 8%

You may not qualify if:

  • \. On insulin for any length of time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2OverweightObesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants will be blinded to the intervention as the shakes will be given in unmarked containers - however as the flavours are very different it is likely that participants will be able to tell them apart. Data analysts will be blinded.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: There is a one-week washout period between intake of the two shakes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2023

First Posted

July 24, 2023

Study Start

November 15, 2023

Primary Completion

May 15, 2024

Study Completion

November 15, 2024

Last Updated

July 24, 2023

Record last verified: 2023-07